Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON20343
NL-OMON20343
Recruiting
Not Applicable

Fecal Immunochemical Testing as a Tool to Determine the Need for Colonoscopy in Symptomatic Patients

Erasmus MC (s-Gravendijkwal 230 3015 CE Rotterdam P.O. Box 2040, 3000 CA Rotterdam Phone: +31 10 704 0704) and Sysmex Europe (Postbus 251 4870 AG Etten-Leur Phone: +31(0)765086000)0 sites807 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsColorectal cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal cancer
Sponsor
Erasmus MC (s-Gravendijkwal 230 3015 CE Rotterdam P.O. Box 2040, 3000 CA Rotterdam Phone: +31 10 704 0704) and Sysmex Europe (Postbus 251 4870 AG Etten-Leur Phone: +31(0)765086000)
Enrollment
807
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Erasmus MC (s-Gravendijkwal 230 3015 CE Rotterdam P.O. Box 2040, 3000 CA Rotterdam Phone: +31 10 704 0704) and Sysmex Europe (Postbus 251 4870 AG Etten-Leur Phone: +31(0)765086000)

Eligibility Criteria

Inclusion Criteria

  • •1\. Referral for a diagnostic colonoscopy because of (new) bowel symptoms.
  • •2\. Able to undergo colonoscopy.

Exclusion Criteria

  • •Subjects will be excluded if they are referred for colonoscopy surveillance for other
  • •indications (including hereditary CRC syndrome, familial CRC syndrome, inflammatory
  • •bowel disease, history of colorectal adenoma or CRC)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Implementation of mailed colon cancer screening testing
ISRCTN22187559Minneapolis VA Health Care System9,000
Recruiting
Not Applicable
Comparison study of two fecal immunochemical tests within a nationwide colorectal cancer screening programscreening, colorectal cancer
NL-OMON26021Erasmus Medical Centre44,038
Completed
Not Applicable
Two-sample FIT-screening: a 4th screening roundcolorectal cancer, screening, darmkanker
NL-OMON20828Erasmus Medical Center3,197
Unknown
Not Applicable
A Prospective Study of a New Immunochemical Fecal Occult Blood Test in U.S. Veteran Patients Undergoing ColonoscopyColon Cancer
NCT00533975University of California, San Diego500
Recruiting
Not Applicable
*The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors*- a pilot studycolitis10017966
NL-OMON42995ederlands Kanker Instituut50